| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Y Meltzer, B L Chai, P A Thompson, B K Yamamot. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. The Journal of pharmacology and experimental therapeutics. vol 268. issue 3. 1994-04-25. PMID:8138957. |
effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. |
1994-04-25 |
2023-08-12 |
rat |
| B T Bloomquist, D N Darlington, R E Mains, B A Eippe. RESP18, a novel endocrine secretory protein transcript, and four other transcripts are regulated in parallel with pro-opiomelanocortin in melanotropes. The Journal of biological chemistry. vol 269. issue 12. 1994-04-21. PMID:8132649. |
adult male rats were treated with bromocriptine, a dopamine agonist, or haloperidol, a dopamine antagonist, for 3 weeks. |
1994-04-21 |
2023-08-12 |
rat |
| H F Luoh, T B Kuo, S H Chan, W H Pa. Power spectral analysis of electroencephalographic desynchronization induced by cocaine in rats: correlation with microdialysis evaluation of dopaminergic neurotransmission at the medial prefrontal cortex. Synapse (New York, N.Y.). vol 16. issue 1. 1994-04-19. PMID:8134898. |
this eeg activation was antagonized by microinfusion into the mpfc via reverse microdialysis of r(+)-sch 23390, a selective antagonist for d-1 receptors; sulpiride, a selective antagonist for d-2 receptors; or haloperidol, a nonspecific dopamine antagonist. |
1994-04-19 |
2023-08-12 |
rat |
| U Renner, J Mojto, M Lange, O A Müller, K von Werder, G K Stall. Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro. European journal of endocrinology. vol 130. issue 1. 1994-04-13. PMID:8124483. |
bromocriptine specifically inhibited growth because its effect could be reversed by the dopamine d2-receptor antagonist haloperidol. |
1994-04-13 |
2023-08-12 |
human |
| F M Scalzo, S F Ali, R R Holson, R L William. Haloperidol effects on the developing dopamine system: conflicting results and implications for neurobehavioral teratology research. Annali dell'Istituto superiore di sanita. vol 29. issue 1. 1994-04-11. PMID:8129260. |
in an attempt to further develop basic principles to guide research in neurobehavioral teratology, six experiments were conducted to examine the effects of prenatal haloperidol (a d2 dopamine antagonist) exposure on striatal d1 and d2 binding sites. |
1994-04-11 |
2023-08-12 |
rat |
| F M Scalzo, S F Ali, R R Holson, R L William. Haloperidol effects on the developing dopamine system: conflicting results and implications for neurobehavioral teratology research. Annali dell'Istituto superiore di sanita. vol 29. issue 1. 1994-04-11. PMID:8129260. |
our initial studies were successful in replicating and extending these previously reported reductions in d2 dopamine binding sites in caudate of rats exposed prenatally to haloperidol. |
1994-04-11 |
2023-08-12 |
rat |
| C C Chien, G W Pasterna. Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma 1 system. European journal of pharmacology. vol 250. issue 1. 1994-04-04. PMID:8119306. |
the antagonism of morphine analgesia by (+)-pentazocine is reversed by haloperidol, a potent dopamine d2 and sigma receptor antagonist. |
1994-04-04 |
2023-08-12 |
Not clear |
| C C Chien, G W Pasterna. Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma 1 system. European journal of pharmacology. vol 250. issue 1. 1994-04-04. PMID:8119306. |
the inactivity of the highly selective dopamine d2 receptor antagonist (-)-sulpiride indicates that both (+)-pentazocine and haloperidol are acting through sigma receptors. |
1994-04-04 |
2023-08-12 |
Not clear |
| I Andia, M Zumarraga, F Retuerto, I Zamalloa, R Davil. Chronic neuroleptic treatment does not suppress the dynamic characteristics of the dopaminergic receptor D2 system. Progress in neuro-psychopharmacology & biological psychiatry. vol 18. issue 1. 1994-03-31. PMID:7906895. |
estimates made twenty hours after the last doses showed that haloperidol reduced the concentrations of the dopamine metabolites, 3,4-dihydroxyphenylacetic acid (dopac) and homovanillic acid (hva) in the striatum and the olfactory tubercle. |
1994-03-31 |
2023-08-12 |
rat |
| I Andia, M Zumarraga, F Retuerto, I Zamalloa, R Davil. Chronic neuroleptic treatment does not suppress the dynamic characteristics of the dopaminergic receptor D2 system. Progress in neuro-psychopharmacology & biological psychiatry. vol 18. issue 1. 1994-03-31. PMID:7906895. |
a challenge dose of either haloperidol or haloperidol plus an anticholinergic drug was administered to rats pretreated with haloperidol or haloperidol plus an anticholinergic drug; this challenge dose reversed the reduction in dopamine metabolites caused by neuroleptic administration. |
1994-03-31 |
2023-08-12 |
rat |
| I Andia, M Zumarraga, F Retuerto, I Zamalloa, R Davil. Chronic neuroleptic treatment does not suppress the dynamic characteristics of the dopaminergic receptor D2 system. Progress in neuro-psychopharmacology & biological psychiatry. vol 18. issue 1. 1994-03-31. PMID:7906895. |
after sixteen months of haloperidol administration dopamine levels were reduced, but adding an anticholinergic drug to haloperidol treatment prevented this reduction in dopamine concentration. |
1994-03-31 |
2023-08-12 |
rat |
| C Matera, S L Wardla. Dopamine and sex steroid regulation of POMC gene expression in the hypothalamus. Neuroendocrinology. vol 58. issue 5. 1994-03-30. PMID:8115018. |
we have therefore measured pomc gene expression and peptide content in the mbh of chronically castrated male and female rats in response to the dopamine antagonist haloperidol, and in intact or sex steroid replaced animals in response to the dopamine agonist pergolide. |
1994-03-30 |
2023-08-12 |
rat |
| K A Freeman, R J Tallarid. A quantitative study of dopamine control in the rat striatum. The Journal of pharmacology and experimental therapeutics. vol 268. issue 2. 1994-03-28. PMID:7906733. |
the dopamine agonists apomorphine and quinpirole and the antagonists haloperidol and sulpiride were individually infused into the rat striatum via the microdialysis probe, and the effect of each on extracellular dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic levels was recorded. |
1994-03-28 |
2023-08-12 |
rat |
| N Bäck, S Soinil. Regulation of secretory granule formation in chronically hypersecretory melanotrophs in the rat pituitary. Cell and tissue research. vol 275. issue 2. 1994-03-28. PMID:8111840. |
hypersecretion was induced by treatment with the dopamine antagonist haloperidol (1.5 mg/kg daily for 7 days), which releases the normal neural dopaminergic inhibition of secretion from the melanotroph. |
1994-03-28 |
2023-08-12 |
rat |
| J R Pednekar, J F Mascarenha. Role of striatal dopamine in the lordosis behaviour. Indian journal of physiology and pharmacology. vol 37. issue 4. 1994-03-28. PMID:8112812. |
effects of intrastriatal injections of haloperidol (dopamine antagonist) and d-amphetamine (dopamine agonist) on lordosis behaviour were studied in ovariectomized female albino rats, after priming with subcutaneous injections of estrogen and progesterone. |
1994-03-28 |
2023-08-12 |
rat |
| G E Drucker, R F Ritzmann, L J Wichlinski, K Engh, J H Gordon, J Z Field. Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves. Pharmacology, biochemistry, and behavior. vol 47. issue 1. 1994-03-25. PMID:8115415. |
chronic administration (21 days) of haloperidol (hal) (ip, 1.0 mg/kg/day) induced a behavioral supersensitivity (stereotypic sniffing) to dopamine (da) agonists (apomorphine) and upregulation (increased bmax for sulpiride-inhibitable [3h]spiroperidol binding) of striatal and limbic d2 da receptors (dar). |
1994-03-25 |
2023-08-12 |
Not clear |
| E R Gillard, D Q Dang, B G Stanle. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain research. vol 628. issue 1-2. 1994-03-23. PMID:8313139. |
in contrast, the dopamine receptor antagonist haloperidol (5 nmol) abolished amph suppression of npy feeding, suggesting that dopamine (da) mediates the amph effect. |
1994-03-23 |
2023-08-12 |
rat |
| J D Salamone, P A Kurth, L D McCullough, J D Sokolowski, M S Cousin. The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain research. vol 628. issue 1-2. 1994-03-23. PMID:8313150. |
the role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. |
1994-03-23 |
2023-08-12 |
rat |
| J D Salamone, P A Kurth, L D McCullough, J D Sokolowski, M S Cousin. The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain research. vol 628. issue 1-2. 1994-03-23. PMID:8313150. |
injections of the dopamine antagonist haloperidol (hp; 0.1, 0.2 and 0.4 mg/kg). |
1994-03-23 |
2023-08-12 |
rat |
| I Panocka, R Ciccocioppo, P Pompei, M Mass. 5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats. Pharmacology, biochemistry, and behavior. vol 46. issue 4. 1994-03-15. PMID:7508629. |
on the other hand, a high risperidone dose (10 mg/kg/day, sc, for 14 days), which produces pronounced dopamine d2 receptor blockade, reduced 8% ethanol preference, like the dopamine receptor antagonist haloperidol. |
1994-03-15 |
2023-08-12 |
rat |